grepafloxacin has been researched along with Infections, Respiratory in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (66.67) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imada, T; Mukai, F; Ohguro, K; Ohmori, K; Tamaoka, H; Wakebe, H; Yabuuchi, Y; Yoneda, H | 1 |
| Johnson, AP; Parsons, T; Warner, M | 1 |
| Geddes, AM | 1 |
| Andrews, JM; Wise, R | 1 |
| Norrby, SR | 1 |
| Elies, W; Lode, H; Vogel, F | 1 |
| Hooper, DC | 2 |
| Felmingham, D | 1 |
| Asherov, J; Dan, M; Poch, F | 1 |
6 review(s) available for grepafloxacin and Infections, Respiratory
| Article | Year |
|---|---|
Grepafloxacin--focus on respiratory infections.
Topics: Anti-Infective Agents; Fluoroquinolones; Humans; Piperazines; Quinolones; Respiratory Tract Infections | 1997 |
Grepafloxacin in respiratory tract infections: are we ready to accept a quinolone for empirical treatment?
Topics: Anti-Infective Agents; Bacterial Infections; Drug Resistance, Microbial; Fluoroquinolones; Humans; Piperazines; Quinolones; Respiratory Tract Infections | 1997 |
Grepafloxacin: a review of its safety profile based on clinical trials and postmarketing surveillance.
Topics: Animals; Anti-Infective Agents; Clinical Trials as Topic; Drug Interactions; Fluoroquinolones; Humans; Piperazines; Product Surveillance, Postmarketing; Quinolones; Respiratory Tract Infections | 1999 |
New fluoroquinolone antibiotics.
Topics: Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Piperazines; Respiratory Tract Infections | 1999 |
New uses for new and old quinolones and the challenge of resistance.
Topics: Anti-Infective Agents; Bacterial Infections; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Piperazines; Respiratory Tract Infections; Sensitivity and Specificity; Sexually Transmitted Diseases; Urinary Tract Infections | 2000 |
The fluoroquinolones after ciprofloxacin and ofloxacin.
Topics: Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Humans; Naphthyridines; Ofloxacin; Piperazines; Respiratory Tract Infections; Sexually Transmitted Diseases, Bacterial; Skin Diseases, Bacterial; Urinary Tract Infections | 2000 |
1 trial(s) available for grepafloxacin and Infections, Respiratory
| Article | Year |
|---|---|
Crossover assessment of serum bactericidal activity of grepafloxacin, ofloxacin and clarithromycin against respiratory pathogens after oral administration to healthy volunteers.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Blood Bactericidal Activity; Clarithromycin; Cross-Over Studies; Female; Fluoroquinolones; Haemophilus influenzae; Humans; In Vitro Techniques; Klebsiella pneumoniae; Male; Moraxella catarrhalis; Ofloxacin; Penicillin Resistance; Piperazines; Respiratory Tract Infections; Streptococcus pneumoniae | 2001 |
5 other study(ies) available for grepafloxacin and Infections, Respiratory
| Article | Year |
|---|---|
Evaluation of OPC-17116 against important pathogens that cause respiratory tract infections.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Fluoroquinolones; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Piperazines; Pneumonia; Quinolones; Rats; Rats, Sprague-Dawley; Respiratory Tract Infections | 1994 |
Activity of grepafloxacin against respiratory isolates of Streptococcus pneumoniae.
Topics: Anti-Infective Agents; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Piperazines; Pneumococcal Infections; Quinolones; Respiratory Tract Infections; Sputum; Streptococcus pneumoniae | 1997 |
[Grepafloxacin (Vaxar)--innovative antibiotic for therapy of respiratory tract infections. Symposium: "Grepafloxacin--a new quinolone designed for respiratory tract infection. Lausanne/Switzerland, 25 May 1997].
Topics: Anti-Infective Agents; Fluoroquinolones; Humans; Piperazines; Quinolones; Respiratory Tract Infections; Switzerland | 1997 |
The activity of grepafloxacin against respiratory pathogens in the UK.
Topics: Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Drug Resistance, Microbial; England; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillin Resistance; Penicillins; Piperazines; Quinolones; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae | 1997 |
Respiratory pathogens: assessing resistance patterns in Europe and the potential role of grepafloxacin as treatment of patients with infections caused by these organisms.
Topics: Anti-Infective Agents; Bacteria; Data Collection; Drug Resistance, Microbial; Europe; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Piperazines; Respiratory Tract Infections | 2000 |